SIP
Click for more information
1.55% $1.31 sigma pharmaceuticals limited

News: SIP Sigma Pharmaceuticals says FY reported EBIT expected to be broadly in line with last year

  1. Hot News
    191,617 Posts.
    lightbulb Created with Sketch. 2809
    clock Created with Sketch.
    17/02/17
    11:30
    Post #: 22695191

    Feb 17 (Reuters) - Sigma Pharmaceuticals Ltd (SIP) :

    • Advise that underlying ebit is expected to be just over $100 million for fy
    • Fy reported ebit is however expected to be broadly in line with last year
    • Sigma pharmaceuticals ltd - "remain comfortable with our existing guidance of at least 5% underlying ebit growth for 2017/18 financial year"
    • Sigma pharmaceuticals - new guidance for full year compares with previous guidance of 10% underlying ebit growth
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

MM1 Geochemical work at Newington picks up gold and copper anomalies for Midas
right-arrow Created with Sketch.
1CG One Click Group surpasses $3M in revenue YTD with 40% growth
right-arrow Created with Sketch.
FHE Frontier Energy lines up $215 million debt financing from Mike Cannon-Brookes-backed Infradebt
right-arrow Created with Sketch.
NEWS Nine staff strike as Paris Olympic coverage begins
right-arrow Created with Sketch.
LKE Lake Resources implies news article on job cuts made up; non-core sales "not material" and no rule 15.7 breach
right-arrow Created with Sketch.
FMG Quarterly & half yearly reports: Drives Newmont up, Ampol flat, while Fortescue plunges 2.6%
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SIP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.